⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
globenewswire.com
NRXP
New to The Street and Wall Street New York Magazine Launch Weekly Executive Publication with Integrated NewsOut Video Press Distribution
accessnewswire.com
VRTX
NRXP
ONCO
LPCN
RDZN
BIVI
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
prnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
globenewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP